Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

Apellis Pharmaceuticals, Inc. · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
c3g, ic-mpgn, c3 glomerulopathy, c3 glomerulonephritis, complement 3 glomerulopathy, complement 3 glomerulopathy (c3g), complement 3 glomerulonephritis, dense deposit disease, ddd, membranoproliferative glomerulonephritis, membranoproliferative glomerulonephritis (mpgn), immune complex membranoproliferative glomerulonephritis (ic-mpgn)
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 807949
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.